Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -86.14 Thousand AUD | -107.72% |
| 2023 | 1.11 Million AUD | -43.63% |
| 2022 | 1.98 Million AUD | 29.18% |
| 2021 | 1.53 Million AUD | 4485.93% |
| 2020 | 33.42 Thousand AUD | 2202.2% |
| 2019 | -1590.00 AUD | 92.11% |
| 2018 | -20.16 Thousand AUD | 45.44% |
| 2017 | -36.95 Thousand AUD | 93.5% |
| 2016 | -568.41 Thousand AUD | -1975.4% |
| 2015 | 30.3 Thousand AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.18 Million AUD | 1.09% |
| 2024 FY | -86.14 Thousand AUD | -107.72% |
| 2024 Q1 | 1.16 Million AUD | 449.51% |
| 2024 Q4 | -43.2 Thousand AUD | 0.0% |
| 2023 FY | 1.11 Million AUD | -43.63% |
| 2023 Q2 | 855.69 Thousand AUD | -0.64% |
| 2023 Q3 | -420.23 Thousand AUD | -149.11% |
| 2023 Q4 | -334.32 Thousand AUD | 20.44% |
| 2023 Q1 | 861.2 Thousand AUD | 56058.41% |
| 2022 Q4 | -1539.00 AUD | 0.0% |
| 2022 FY | 1.98 Million AUD | 29.18% |
| 2022 Q2 | -1670.00 AUD | 0.0% |
| 2021 Q4 | -472.00 AUD | 0.0% |
| 2021 Q2 | -200.00 AUD | 0.0% |
| 2021 FY | 1.53 Million AUD | 4485.93% |
| 2020 Q4 | -400.00 AUD | 0.0% |
| 2020 FY | 33.42 Thousand AUD | 2202.2% |
| 2020 Q2 | -401.00 AUD | 0.0% |
| 2019 FY | -1590.00 AUD | 92.11% |
| 2018 FY | -20.16 Thousand AUD | 45.44% |
| 2017 FY | -36.95 Thousand AUD | 93.5% |
| 2016 FY | -568.41 Thousand AUD | -1975.4% |
| 2015 FY | 30.3 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.574% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 2877.208% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.88% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.736% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.072% |
| Mesoblast Limited | -35.16 Million USD | 99.755% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -152.266% |
| Genus plc | 178.7 Million USD | 100.048% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 121.003% |
| Marizyme, Inc. | 457.7 Thousand USD | 118.822% |
| ContraFect Corporation | -154 Thousand USD | 44.059% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -683.173% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -72.298% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 212.23% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 231.069% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 77.768% |
| MultiCell Technologies, Inc. | 49.32 USD | 174773.56% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.214% |
| EV Biologics, Inc. | 48.9 Thousand USD | 276.174% |
| Q BioMed Inc. | -8988.00 USD | -858.489% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.305% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -458.539% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.039% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 223.07% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 30.665% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 238.445% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -1639.681% |
| Arch Therapeutics, Inc. | -2439.00 USD | -3432.144% |
| IMV Inc. | -962.29 Thousand USD | 91.048% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 161.316% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 11.656% |
| GB Sciences, Inc. | -624.00 USD | -13705.929% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -0.141% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.001% |
| Halberd Corporation | -208.00 USD | -41317.788% |
| Enzolytics Inc. | 30.7 Thousand USD | 380.543% |
| Resverlogix Corp. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 106.348% |
| SYBLEU INC | 11.69 Thousand USD | 836.568% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 117.857% |
| argenx SE | 1.1 Billion USD | 100.008% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.666% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 113.954% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.021% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -872.776% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.194% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 92.453% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 108.72% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.896% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -2.743% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.559% |
| ONE Bio Corp. | 20.12 Million USD | 100.428% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Agentix Corp. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -627.917% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -78.514% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 148.793% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 148.793% |
| NovAccess Global Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 83.256% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 86.329% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -197.066% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 119.142% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 73.037% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 101.87% |
| Bioxytran, Inc. | -8285.00 USD | -939.819% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 76.904% |
| Neutra Corp. | 14.33 Thousand USD | 700.97% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -5.06% |
| PureTech Health plc | -1.6 Million USD | 94.626% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 91.396% |
| IXICO plc | 3.27 Million USD | 102.635% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 87.587% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 95.19% |
| CSL Limited | 7.7 Billion USD | 100.001% |
| Cellectis S.A. | 18 Thousand USD | 578.606% |